Özcan Met

Özcan Met

Visiting associate professor, Gæstelektor

Member of:

    ORCID: 0000-0002-3256-7592

    Publication year:
    All
    31 - 40 out of 78Page size: 10
    1. 2016
    2. Published

      mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma

      Borch, T. H., Engell-Noerregaard, L., Iversen, T. Z., Ellebaek, E., Met, Özcan, Hansen, M., Andersen, Mads Hald, thor Straten, E. P. & Svane, Inge Marie, 1 Sep 2016, In: OncoImmunology. 5, 9, 12 p., e1207842.

      Research output: Contribution to journal › Journal article › Research › peer-review

    3. 2017
    4. Published

      The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms

      Holmström, M. O., Hjortso, M. D., Ahmad, S. M., Met, Özcan, Martinenaite, E., Riley, C., Straten, P., Svane, Inge Marie, Hasselbalch, Hans Carl & Andersen, Mads Hald, 2017, In: Leukemia. 31, p. 495-498

      Research output: Contribution to journal › Letter › Research › peer-review

    5. Published

      Dendritic cell vaccination in combination with docetaxel for patients with metastatic castration-resistant prostate cancer: A randomized phase II study

      Kongsted, P., Borch, T. H., Ellebaek, E., Iversen, T. Z., Andersen, R., Met, Özcan, Hansen, M., Lindberg, H., Sengeløv, L. & Svane, Inge Marie, 1 Apr 2017, In: Cytotherapy. 19, 4, p. 500-513 14 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    6. 2018
    7. Published

      Chemokine receptor engineering of T cells with CXCR2 improves homing towards subcutaneous human melanomas in xenograft mouse model

      Idorn, M., Skadborg, S. K., Kellermann, L., Halldórsdóttir, H. R., Holmen Olofsson, G., Met, Özcan & thor Straten, P., 2018, In: OncoImmunology. 7, 8, 10 p., e1450715.

      Research output: Contribution to journal › Journal article › Research › peer-review

    8. Published

      Frequent adaptive immune responses against arginase-1

      Martinenaite, E., Mortensen, R. E. J., Hansen, M., Orebo Holmström, M., Munir Ahmad, S., Grønne Dahlager Jørgensen, N., Met, Özcan, dqp123, dqp123, Svane, Inge Marie & Andersen, Mads Hald, 2018, In: OncoImmunology. 7, 3, 9 p., e1404215.

      Research output: Contribution to journal › Journal article › Research › peer-review

    9. Published

      Improved migration of tumor ascites lymphocytes to ovarian cancer microenvironment by CXCR2 transduction

      Idorn, M., Olsen, M., Halldórsdóttir, H. R., Skadborg, S. K., Pedersen, M., Høgdall, Claus Kim, Høgdall, Estrid Vilma Solyom, Met, Özcan & thor Straten, P., 2018, In: OncoImmunology. 7, 4, 12 p., e1412029.

      Research output: Contribution to journal › Journal article › Research › peer-review

    10. Published

      SATB1 in malignant T cells

      Fredholm, S. M., Willerslev-Olsen, A., Met, Ö., Kubat, L., Gluud, M., Mathiasen, S. L., Friese, C., Blümel, E., Petersen, D. L., Hu, T., Nastasi, C., Lindahl, L. M., Buus, T. B., Krejsgaard, T. F., Wasik, M. A., Kopp, K. L. M., Koralov, S. B., Persson, J. L., Bonefeld, C. M., Geisler, C. & 4 others, Woetmann, Anders , Iversen, L., Becker, J. C. & Ødum, Niels, 2018, In: The Journal of Investigative Dermatology. 138, 8, p. 1805-1815 11 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    11. Published

      T cells isolated from patients with checkpoint inhibitor-resistant melanoma are functional and can mediate tumor regression

      Andersen, R., Borch, T. H., Draghi, A., Gokuldass, A., Rana, M. A. H., Pedersen, M., Nielsen, M., Kongsted, P., Kjeldsen, J. W., Westergaard, M. C. W., Radic, H. D., Chamberlain, C. A., Hølmich, Lisbet Rosenkrantz, Hendel, Helle Westergren, Larsen, M. S., Met, Özcan, Svane, Inge Marie & dqp123, dqp123, 2018, In: Annals of Oncology. 29, 7, p. 1575-1581 7 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    12. Published

      T-cell Responses in the Microenvironment of Primary Renal Cell Carcinoma-Implications for Adoptive Cell Therapy

      Andersen, R., Westergaard, M. C. W., Kjeldsen, J. W., Müller, A., Pedersen, N. W., Hadrup, S. R., Met, Özcan, Seliger, B., Kromann-Andersen, B., Hasselager, T., dqp123, dqp123 & Svane, Inge Marie, 2018, In: Cancer Immunology Research. 6, 2, p. 222-235 14 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    13. Published

      The inhibitory checkpoint, PD-L2, is a target for effector T cells: Novel possibilities for immune therapy

      Ahmad, S. M., Martinenaite, E., Holmström, M., Jørgensen, M. A., Met, Özcan, Nastasi, C., Klausen, U., dqp123, dqp123, Pedersen, Lars Møller, Munksgaard, Lars, Ødum, Niels, Woetmann, Anders , Svane, Inge Marie & Andersen, Mads Hald, 2018, In: OncoImmunology. 7, 2, 10 p., e1390641.

      Research output: Contribution to journal › Journal article › Research › peer-review

    Previous 1 2 3 4 5 6 7 8 Next

    ID: 33971757